Rho to Discuss Clinical Trial Experience at American Pain Society 35th Annual Scientific Meeting 2016
CHAPEL HILL, NC, UNITED STATES - May 10, 2016 -
WHAT: Rho, a full-service contract research organization (CRO), will highlight its clinical trial expertise during the American Pain Societys (APS) 35th Annual Scientific Meeting, being held May 11-14 in Austin, Texas. Rho will also sponsor a pre-conference workshop May 11 from 8 a.m. to 5 p.m. for Optimizing Analgesia Clinical Trials Conduct, gathering world-renowned experts to share best practices, discuss experimental methods, highlight common clinical pain models and facilitate future collaboration.
Several Rho experts will be in attendance at the meeting, discussing topics ranging from project management to clinical safety. Event attendees are invited to stop by Rhos booth (#717) to meet the experts and learn more about how the company can help ensure an efficient and a successful drug development process.
Rho focuses on helping pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, including clinical operations, project management, data management, data standards, and biostatistics, with extensive experience in pain products.
WHO: Rho expert at APS Annual Meeting 2016:
- Jack Modell, senior medical officer
- Emily Cantrell, senior director of operations
- Ben Vaughn, statistical scientist
WHEN: May 11-14, 2016
WHERE: Austin Convention Center Congress Center
Booth #717
500 E Cesar Chavez St.
Austin, TX 78701
DETAILS: For media inquiries, please contact Bernadette Miller at Largemouth Communications, (703) 297-5992, bernadette@largemouthpr.com.
ABOUT: Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 32 years, Rho has been a trusted partner to some of the industrys leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.
###